Search

Author/Creator Martin, Jonathan

4. Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine. (6th November 2014)

Authors:
Greene, Julia; Schneble, Erika; Martin, Jonathan; Flores, Maddie; Trappey, Alfred; Berry, John; Vreeland, Timothy; Hale, Diane; Clifton, Guy; Perez, Sonia A; Papamichail, Michael; Peoples, George; Mittendorf, Elizabeth; Ponniah, Sathibalan
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. (5th July 2019)

Authors:
Brown, Tommy A.; Byrd, Kevin; Vreeland, Timothy J.; Clifton, Guy T.; Jackson, Doreen O.; Hale, Diane F.; Herbert, Garth S.; Myers, John W.; Greene, Julia M.; Berry, John S.; Martin, Jonathan; Elkas, John C.; Conrads, Thomas P.; Darcy, Kathleen M.; Hamilton, Chad A.; Maxwel, George L.; Peoples, Ge...
Journal:
Cancer medicine
Issue:
Volume 8:Number 10(2019:Aug.)
Page Start:
4678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗